Gapping down
In reaction to disappointing earnings/guidance: URBN -13.6%, (reports Q3 negative comparable retail segment net sale has continued quarter-to-date; gross profit margin may deleverage at a rate greater than during 1H), SNDK -2.8%, ATHN -2%, AMD -1.1%, GOOG -0.9%, COF -0.7%
M&A news: CF -3.9% (announced the termination of merger discussions with Yara International)
Other news: RPRX -40.6% (announces upcoming FDA meeting to be Type C meeting instead of Type B Pre-NDA meeting), CCL -3.4% (Health Care worker who may have handled Thomas Duncan's Ebola lab specimens has been isolated on CCL ship, according to reports), RCL -3% (in symp with CCL news), ANF -1.7% (following URBN guidance), AEO -1.2% (following URBN guidance),EARN -1.1% (co requested the withdrawal of its registration statement on Form S-11; intends to register on Form S-3)
In reaction to disappointing earnings/guidance: URBN -13.6%, (reports Q3 negative comparable retail segment net sale has continued quarter-to-date; gross profit margin may deleverage at a rate greater than during 1H), SNDK -2.8%, ATHN -2%, AMD -1.1%, GOOG -0.9%, COF -0.7%
M&A news: CF -3.9% (announced the termination of merger discussions with Yara International)
Other news: RPRX -40.6% (announces upcoming FDA meeting to be Type C meeting instead of Type B Pre-NDA meeting), CCL -3.4% (Health Care worker who may have handled Thomas Duncan's Ebola lab specimens has been isolated on CCL ship, according to reports), RCL -3% (in symp with CCL news), ANF -1.7% (following URBN guidance), AEO -1.2% (following URBN guidance),EARN -1.1% (co requested the withdrawal of its registration statement on Form S-11; intends to register on Form S-3)